首页> 美国卫生研究院文献>Journal of Clinical Oncology >Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

【2h】

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

机译：DASISION的最终5年研究结果：达沙替尼与伊马替尼的研究在未接受过治疗的慢性粒细胞白血病患者中进行了试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeWe report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term efficacy and safety outcomes of patients with chronic myeloid leukemia (CML) in chronic phase (CP) treated with dasatinib or imatinib.

机译：目的我们报告了Dasatinib与Imatinib III期研究在未经治疗的慢性粒细胞白血病患者（DASISION）试验中进行的5年分析，评估了慢性粒细胞白血病（CML）慢性期（CP）患者的长期疗效和安全性结果）用达沙替尼或伊马替尼治疗。

著录项

期刊名称 Journal of Clinical Oncology
作者
Jorge E. Cortes; Giuseppe Saglio; Hagop M. Kantarjian; Michele Baccarani; Jiří Mayer; Concepción Boqué; Neil P. Shah; Charles Chuah; Luis Casanova; Brigid Bradley-Garelik; George Manos; Andreas Hochhaus;
展开▼
作者单位

展开▼
年(卷),期 -1(34),20
年度 -1
页码 2333–2340
总页数 15
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial [J] . Cortes Jorge E., Saglio Giuseppe, Kantarjian Hagop M., Journal of Clinical Oncology . 2016,第20期

机译：DASISION的最终5年研究结果：达沙替尼与伊马替尼的研究在未经治疗的慢性粒细胞白血病患者中进行了试验
2. Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report [J] . Nakamae Hirohisa, Fujisawa Shin, Ogura Michinori, International journal of hematology . 2017,第6期

机译：Dasatinib与伊马替尼在日本患者新诊断的慢性相慢性骨髓白血病：Dasision 5年的最终报告的子分析
3. Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up [J] . Shin Fujisawa, Hirohisa Nakamae, Michinori Ogura, International journal of hematology . 2014,第2期

机译：达沙替尼与伊马替尼在日本新诊断的慢性期慢性粒细胞白血病（CML-CP）患者中的疗效和安全性：DASISION试验的亚组分析，为期两年
4. Combination effects of repetitive pulsed magnetic stimulation and tyrosine kinase inhibitor imatinib for chronic myeloid leukemia cell line TCC-S [C] . S. Yamaguchi, M. Sekino, Y. Sato, Intermag Conference . 2006

机译：重复脉冲磁刺激和酪氨酸激酶抑制剂慢性髓性白血病细胞系TCC-S的组合效应
5. Influences on physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia patients. [D] . Iyer, Shrividya Sethuraman. 2003

机译：对慢性期慢性粒细胞白血病患者甲磺酸伊马替尼的医师推荐的影响。
6. Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase [O] . Charles T. Chuah, Hirohisa Nakamae, Zhixiang X. Shen, -1

机译：达沙替尼与伊马替尼在慢性期新诊断的慢性粒细胞白血病DASISION试验的东亚亚群中的疗效和安全性
7. Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia:2-year follow-up from a randomized phase 3 trial (DASISION) [O] . Kantarjian, Hagop M., Shah, Neil P., Cortes, Jorge E., 2012

机译：达沙替尼或伊马替尼用于新诊断的慢性期慢性粒细胞白血病：一项为期3年的随机研究（DASISION），为期2年的随访

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

摘要

著录项

相似文献

相关主题

期刊订阅